1h Free Analyst Time
The publisher has been monitoring the dental biomaterials market and it is poised to grow by $492.69 mn during 2021-2025, progressing at a CAGR of 8.41% during the forecast period. The report on the dental biomaterials market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of dental diseases and related risk factors and the use of intraoral scanners and open architecture solutions.
The dental biomaterials market analysis includes the product segment and geographic landscape.
The dental biomaterials market is segmented as below:
By Product
- Bone grafts
- Membranes and tissue regeneration products
By Geographic
- North America
- Europe
- Asia
- ROW
This study identifies the rise in the adoption rate of CAD/CAM technology as one of the prime reasons driving the dental biomaterials market growth during the next few years.
The report on dental biomaterials market covers the following areas:
- Dental biomaterials market sizing
- Dental biomaterials market forecast
- Dental biomaterials market industry analysis
The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading dental biomaterials market vendors that include Advanced Medical Solutions Group Plc, Augma Biomaterials USA Inc., DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc. Also, the dental biomaterials market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.
Table of Contents
Executive Summary- Market Overview
Market Landscape
- Market ecosystem
- Value Chain Analysis
Market Sizing
- Market definition
- Market segment analysis
- Market size 2021
- Market outlook: Forecast for 2020 - 2025
Five Forces Analysis
- Five Forces Summary
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition
Market Segmentation by Product
- Market segments
- Membranes and tissue regeneration products - Market size and forecast 2020-2025
- Market opportunity by Product
Customer landscape
- Overview
- Customer landscape
Geographic Landscape
- Geographic segmentation
- Geographic comparison
- North America - Market size and forecast 2020-2025
- Europe - Market size and forecast 2020-2025
- Asia - Market size and forecast 2020-2025
- ROW - Market size and forecast 2020-2025
- Key leading countries
- Market opportunity By Geographical Landscape
Drivers, Challenges, and Trends
- Market drivers
- Market challenges
- Market trends
Vendor Landscape
- Overview
- Landscape disruption
- Competitive Scenario
Vendor Analysis
- Vendors covered
- Market positioning of vendors
- Advanced Medical Solutions Group Plc
- Augma Biomaterials USA Inc.
- ENTSPLY SIRONA Inc.
- Envista Holdings Corp.
- Geistlich Pharma AG
- Henry Schein Inc.
- Medtronic Plc
- Straumann Holding AG
- Tissue Regenix Group Plc
- Zimmer Biomet Holdings Inc.
Appendix
- Scope of the report
- Currency conversion rates for US$
- Research Methodology
- List of abbreviations
List of Exhibits
- Key Finding 1
- Key Finding 2
- Key Finding 3
- Key Finding 5
- Key Finding 6
- Key Finding 7
- Key Finding 8
- Parent market
- Market characteristics
- Offerings of vendors included in the market definition
- Market segments
- Global - Market size and forecast 2020 - 2025 ($ million)
- Global market: Year-over-year growth 2020 - 2025 (%)
- Five forces analysis 2020 & 2025
- Bargaining power of buyers
- Bargaining power of suppliers
- Threat of new entrants
- Threat of substitutes
- Threat of rivalry
- Market condition - Five forces 2020
- Product - Market share 2020-2025 (%)
- Comparison by Product
- Bone grafts - Market size and forecast 2020-2025 ($ million)
- Bone grafts - Year-over-year growth 2020-2025 (%)
- Membranes and tissue regeneration products - Market size and forecast 2020-2025 ($ million)
- Membranes and tissue regeneration products - Year-over-year growth 2020-2025 (%)
- Market opportunity by Product
- Customer landscape
- Market share By Geographical Landscape 2020-2025 (%)
- Geographic comparison
- North America - Market size and forecast 2020-2025 ($ million)
- North America - Year-over-year growth 2020-2025 (%)
- Europe - Market size and forecast 2020-2025 ($ million)
- Europe - Year-over-year growth 2020-2025 (%)
- Asia - Market size and forecast 2020-2025 ($ million)
- Asia - Year-over-year growth 2020-2025 (%)
- ROW - Market size and forecast 2020-2025 ($ million)
- ROW - Year-over-year growth 2020-2025 (%)
- Key leading countries
- Market opportunity By Geographical Landscape ($ million)
- Impact of drivers and challenges
- Vendor landscape
- Landscape disruption
- Industry risks
- Vendors covered
- Market positioning of vendors
- Advanced Medical Solutions Group Plc - Overview
- Advanced Medical Solutions Group Plc - Business segments
- Advanced Medical Solutions Group Plc - Key offerings
- Advanced Medical Solutions Group Plc - Key customers
- Advanced Medical Solutions Group Plc - Segment focus
- Augma Biomaterials USA Inc. - Overview
- Augma Biomaterials USA Inc. - Product and service
- Augma Biomaterials USA Inc. - Key offerings
- Augma Biomaterials USA Inc. - Key customers
- Augma Biomaterials USA Inc. - Segment focus
- DENTSPLY SIRONA Inc. - Overview
- DENTSPLY SIRONA Inc. - Business segments
- DENTSPLY SIRONA Inc. - Key offerings
- DENTSPLY SIRONA Inc. - Key customers
- DENTSPLY SIRONA Inc. - Segment focus
- Envista Holdings Corp. - Overview
- Envista Holdings Corp. - Business segments
- Envista Holdings Corp. - Key offerings
- Envista Holdings Corp. - Key customers
- Envista Holdings Corp. - Segment focus
- Geistlich Pharma AG - Overview
- Geistlich Pharma AG - Product and service
- Geistlich Pharma AG - Key offerings
- Geistlich Pharma AG - Key customers
- Geistlich Pharma AG - Segment focus
- Henry Schein Inc. - Overview
- Henry Schein Inc. - Business segments
- Henry Schein Inc. - Key offerings
- Henry Schein Inc. - Key customers
- Henry Schein Inc. - Segment focus
- Medtronic Plc - Overview
- Medtronic Plc - Business segments
- Medtronic Plc - Key offerings
- Medtronic Plc - Key customers
- Medtronic Plc - Segment focus
- Straumann Holding AG - Overview
- Straumann Holding AG - Business segments
- Straumann Holding AG - Key offerings
- Straumann Holding AG - Key customers
- Straumann Holding AG - Segment focus
- Tissue Regenix Group Plc - Overview
- Tissue Regenix Group Plc - Business segments
- Tissue Regenix Group Plc - Key offerings
- Tissue Regenix Group Plc - Key customers
- Tissue Regenix Group Plc - Segment focus
- Zimmer Biomet Holdings Inc. - Overview
- Zimmer Biomet Holdings Inc. - Business segments
- Zimmer Biomet Holdings Inc. - Key offerings
- Zimmer Biomet Holdings Inc. - Key customers
- Zimmer Biomet Holdings Inc. - Segment focus
- Currency conversion rates for US$
- Research Methodology
- Validation techniques employed for market sizing
- Information sources
- List of abbreviations
Executive Summary
The publisher recognizes the following companies as the key players in the global dental biomaterials market: Advanced Medical Solutions Group Plc, Augma Biomaterials USA Inc., DENTSPLY SIRONA Inc., Envista Holdings Corp., Geistlich Pharma AG, Henry Schein Inc., Medtronic Plc, Straumann Holding AG, Tissue Regenix Group Plc, and Zimmer Biomet Holdings Inc.Commenting on the report, an analyst from the research team said: 'The latest trend gaining momentum in the market is rise in the adoption rate of CAD/CAM technology.'
According to the report, one of the major drivers for this market is the increasing prevalence of dental diseases and related risk factors.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advanced Medical Solutions Group Plc
- Augma Biomaterials USA Inc.
- DENTSPLY SIRONA Inc.
- Envista Holdings Corp.
- Geistlich Pharma AG
- Henry Schein Inc.
- Medtronic Plc
- Straumann Holding AG
- Tissue Regenix Group Plc
- Zimmer Biomet Holdings Inc.
